Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Alice Caldiroli, Enrico Capuzzi, Ilaria Tagliabue, Luisa Ledda, Massimo Clerici & Massimiliano Buoli. (2023) New frontiers in the pharmacological treatment of social anxiety disorder in adults: an up-to-date comprehensive overview. Expert Opinion on Pharmacotherapy 24:2, pages 207-219.
Read now
Read now
Jonathan C Ipser, Catherine M Kariuki & Dan J Stein. (2008) Pharmacotherapy for social anxiety disorder: a systematic review. Expert Review of Neurotherapeutics 8:2, pages 235-257.
Read now
Read now
Articles from other publishers (18)
Taryn Williams, Coenie J Hattingh, Catherine M Kariuki, Sean A Tromp, Anton J van Balkom, Jonathan C Ipser & Dan J Stein. (2017) Pharmacotherapy for social anxiety disorder (SAnD). Cochrane Database of Systematic Reviews 2019:1.
Crossref
Crossref
Matthew A. Fuller. 2016. The Medical Basis of Psychiatry. The Medical Basis of Psychiatry
707
780
.
Denise M. Ginzburg, Franziska Schreiber & Ulrich Stangier. 2014. The Wiley Handbook of Anxiety Disorders. The Wiley Handbook of Anxiety Disorders
964
1002
.
Dan J. Stein, David S. Baldwin, Borwin Bandelow, Carlos Blanco, Leonardo F. Fontenelle, Sing Lee, Hisato Matsunaga, David Osser, Murray B. Stein & Michael van Ameringen. (2010) A 2010 Evidence-Based Algorithm for the Pharmacotherapy of Social Anxiety Disorder. Current Psychiatry Reports 12:5, pages 471-477.
Crossref
Crossref
Anton Y. Bespalov, Marcel M. van Gaalen & Gerhard Gross. 2010. Behavioral Neurobiology of Anxiety and Its Treatment. Behavioral Neurobiology of Anxiety and Its Treatment
361
390
.
Paul J. Perry, Heidi J. Wehring, Bruce Alexander & Barry Liskow. 2008. The Medical Basis of Psychiatry. The Medical Basis of Psychiatry
577
634
.
Sheila V. Stager, Karim Calis, Dale Grothe, Meir Bloch, Nannette M. Berensen, Paul J. Smith & Allen Braun. (2005) Treatment with medications affecting dopaminergic and serotonergic mechanisms: Effects on fluency and anxiety in persons who stutter. Journal of Fluency Disorders 30:4, pages 319-335.
Crossref
Crossref
Dan J Stein, Jonathan C Ipser & Anton J van Balkom. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
H. J. Möller, H. Grunze, U. Hegerl, V. Henkel, M. Bauer, G. Laux, R. J. Boerner, A. Broocks, A. Kordon, F. Hohagen, M. M. Fichter & R. Würz. 2002. Neuro-Psychopharmaka Ein Therapie-Handbuch. Neuro-Psychopharmaka Ein Therapie-Handbuch
651
780
.
David L. Dunner. (2001) Management of anxiety disorders: The added challenge of comorbidity. Depression and Anxiety 13:2, pages 57-71.
Crossref
Crossref
Sharon C. Cheetham & David J. Heal. 2000. Biological Psychiatry. Biological Psychiatry
511
567
.
Antonio Egidio Nardi. (1999) O tratamento farmacológico da fobia social. Revista Brasileira de Psiquiatria 21:4, pages 249-257.
Crossref
Crossref
V. Caillard, F. Rouillon, J. F. Viel & S. Markabi. (2007) Comparative effects of low and high doses of clomipramine and placebo in panic disorder: a double‐blind controlled study. Acta Psychiatrica Scandinavica 99:1, pages 51-58.
Crossref
Crossref
DAVID J. NUTT & PAUL GLUE. 1991. Psychopharmacology of Anxiolytics and Antidepressants. Psychopharmacology of Anxiolytics and Antidepressants
1
28
.
David J. Nutt. (1990) The pharmacology of human anxiety. Pharmacology & Therapeutics 47:2, pages 233-266.
Crossref
Crossref
Jose L. Ayuso, Susana Alfonso & Alvaro Rivera. (1989) Childhood separation anxiety and panic disorder: A comparative study. Progress in Neuro-Psychopharmacology and Biological Psychiatry 13:5, pages 665-671.
Crossref
Crossref
David J. Nutt & Paul Glue. (1989) Clinical pharmacology of anxiolytics and antidepressants: A psychopharmacological perspective. Pharmacology & Therapeutics 44:3, pages 309-334.
Crossref
Crossref
Kjell Modigh. (1987) Antidepressant drugs in anxiety disorders. Acta Psychiatrica Scandinavica 76:S335, pages 57-71.
Crossref
Crossref